ATE523519T1 - Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targets - Google Patents
Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targetsInfo
- Publication number
- ATE523519T1 ATE523519T1 AT06755941T AT06755941T ATE523519T1 AT E523519 T1 ATE523519 T1 AT E523519T1 AT 06755941 T AT06755941 T AT 06755941T AT 06755941 T AT06755941 T AT 06755941T AT E523519 T1 ATE523519 T1 AT E523519T1
- Authority
- AT
- Austria
- Prior art keywords
- macrolide
- biotin
- affinity group
- target
- identifying
- Prior art date
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229960002685 biotin Drugs 0.000 title abstract 2
- 235000020958 biotin Nutrition 0.000 title abstract 2
- 239000011616 biotin Substances 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64433305P | 2005-01-14 | 2005-01-14 | |
| PCT/IB2006/001484 WO2006106440A1 (en) | 2005-01-14 | 2006-01-13 | Macrolide compounds containing biotin and photo-affinity group for macrolide target identification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE523519T1 true ATE523519T1 (de) | 2011-09-15 |
Family
ID=36808715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06755941T ATE523519T1 (de) | 2005-01-14 | 2006-01-13 | Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targets |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7989600B2 (de) |
| EP (1) | EP1836212B1 (de) |
| JP (1) | JP5065910B2 (de) |
| AT (1) | ATE523519T1 (de) |
| ES (1) | ES2371931T3 (de) |
| WO (1) | WO2006106440A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1638549A4 (de) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | Neue antibakterielle mittel |
| PT1851236E (pt) | 2005-01-13 | 2010-10-25 | Glaxosmithkline Zagreb | Macrólidos com actividade anti-inflamatória |
| RU2455308C2 (ru) * | 2006-05-01 | 2012-07-10 | Тайсо Фармасьютикал Ко., Лтд. | Макролидные производные |
| TWI519508B (zh) * | 2007-06-12 | 2016-02-01 | Achaogen Inc | 抗菌劑 |
| EP2214484A4 (de) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | Verfahren zur herstellung von antibakteriellen makrolid-wirkstoffen |
| JP5711135B2 (ja) | 2008-10-24 | 2015-04-30 | センプラ ファーマシューティカルズ，インコーポレイテッド | 胃腸疾患を治療するための方法 |
| CN102378763A (zh) * | 2009-01-30 | 2012-03-14 | 葛兰素集团有限公司 | 消炎的大环内酯 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| ES2608285T3 (es) | 2009-09-10 | 2017-04-07 | Cempra Pharmaceuticals, Inc. | Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC |
| EP2613630A4 (de) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | Wasserstoffbindung zur formung von fluorketoliden zur behandlung von krankheiten |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| AU2014239959A1 (en) | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
| US11197872B2 (en) | 2017-04-21 | 2021-12-14 | Lunella Biotech, Inc. | Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs) |
| EP3612177A4 (de) | 2017-04-21 | 2021-01-13 | Lunella Biotech, Inc. | Targeting von hypoxischen krebsstammzellen (cscs) mit doxycyclin: implikationen zur verbesserung der anti-angiogenesetherapie |
| PH12019502594A1 (en) | 2017-05-19 | 2020-10-26 | Lunella Biotech Inc | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| CA3063450A1 (en) | 2017-05-19 | 2018-11-22 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
| KR102854338B1 (ko) | 2017-06-26 | 2025-09-03 | 루넬라 바이오테크 인코포레이티드 | 미토케토신: 암 세포에서 케톤 대사를 표적화하는 미토콘드리아-기반의 치료제 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005095014A (ja) | 2003-09-22 | 2005-04-14 | Science Univ Of Tokyo | マクロライド系抗生物質結合ペプチド及びこれをコードする遺伝子 |
-
2006
- 2006-01-13 EP EP06755941A patent/EP1836212B1/de not_active Expired - Lifetime
- 2006-01-13 AT AT06755941T patent/ATE523519T1/de not_active IP Right Cessation
- 2006-01-13 WO PCT/IB2006/001484 patent/WO2006106440A1/en not_active Ceased
- 2006-01-13 ES ES06755941T patent/ES2371931T3/es not_active Expired - Lifetime
- 2006-01-13 JP JP2007550882A patent/JP5065910B2/ja not_active Expired - Fee Related
- 2006-01-13 US US11/813,871 patent/US7989600B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006106440A1 (en) | 2006-10-12 |
| EP1836212A1 (de) | 2007-09-26 |
| ES2371931T3 (es) | 2012-01-11 |
| JP2008526952A (ja) | 2008-07-24 |
| EP1836212B1 (de) | 2011-09-07 |
| US7989600B2 (en) | 2011-08-02 |
| JP5065910B2 (ja) | 2012-11-07 |
| US20080241959A1 (en) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE523519T1 (de) | Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targets | |
| EA200802074A1 (ru) | Способ получения бисфуранового спирта, соединения, соль, фармацевтическая композиция на ее основе, способ для лечения или профилактики ретровирусных инфекций с ее помощью и способ ингибирования вич протеазы с ее помощью | |
| ECSP077249A (es) | Nuevos hidratos y polimorfos de 4-[[(7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil]amino]-3-metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparación y su uso como fármaco | |
| BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
| EA200970207A1 (ru) | Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов | |
| CL2012000033A1 (es) | Compuestos n-(3-(4as,7as)-2-amino-4a,5,7,7a-tetrahidro-4h-furo[3,4-d][1,3] tiazin-7a-il)-4- fluorofenilo) -5-fluoropiconilamida, inhibidor de bace; composicion farmaceutica que los comprende, uso del compuesto para el tratamiento de la enfermedad de alzheimer. | |
| BRPI0518459A2 (pt) | composto ou um sal farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar o composto ou um sal farmaceuticamente aceitÁvel do mesmo | |
| UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
| BRPI0418639A (pt) | inibidores de dipeptidil peptidase | |
| CY1109339T1 (el) | Υποκατεστημενες ενωσεις 1-οξα-3,8-διαζασπειρο[4.5]-δεκαν-2-ονης και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
| CR10157A (es) | Compuestos químicos | |
| TNSN08407A1 (en) | Organic compounds | |
| PT1791571E (pt) | Péptidos radiofluorados | |
| WO2008044243A3 (en) | Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| BRPI0821102A2 (pt) | Preparação de derivados de di-hidropirrol como intermediários | |
| BRPI0518647A2 (pt) | processo para a produÇço de um composto, e, composto | |
| PA8804601A1 (es) | 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antiinflamatorios. | |
| TW200942529A (en) | Pyrrolidinyl derivatives and uses thereof | |
| EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
| UY30788A1 (es) | Compuestos quimicos | |
| CR11084A (es) | Compuesto biciclico y uso farmaceutico del mismo | |
| DK1824479T3 (da) | Phenylpiperazin-derivater med en kombination af delvis dopamin-D2-receptoragonisme og serotonin-genoptagelsesinhibering | |
| EA200701676A1 (ru) | Производные дигидроимидазотиазола | |
| AR064467A1 (es) | Derivados de antraquinona como sustancias marcadoras para liquidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |